Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlisimod in Dry Eye Disease
NCT04535947Phase 2Completed
- Sponsor
- Silk Technologies, Ltd.
- Start
- Aug 2020
- Primary completion
- Feb 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amlisimod in dry eye disease (DED), sponsored by Silk Technologies, Ltd.. Started Aug 2020; status: completed.
02
Drugs
amlisimod
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04535947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04535947.